Qube Research & Technologies LTD Adaptive Biotechnologies Corp Transaction History

Qube Research & Technologies LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$3.46 - $5.33 $35,008 - $53,928	-10,118 Reduced 16.71%	50,448 $247,000
Q3 2023 Nov 13, 2023	BUY	$5.07 - $8.44 $97,927 - $163,018	19,315 Added 46.82%	60,566 $330,000
Q2 2023 Aug 14, 2023	SELL	$6.19 - $8.78 $139,244 - $197,506	-22,495 Reduced 35.29%	41,251 $276,000
Q1 2023 May 15, 2023	BUY	$7.8 - $10.11 $497,218 - $644,472	63,746 New	63,746 $562,000
Q3 2022 Nov 14, 2022	BUY	$6.5 - $12.67 $149,110 - $290,649	22,940 Added 36.22%	86,280 $614,000
Q2 2022 Aug 15, 2022	BUY	$6.4 - $14.73 $61,881 - $142,424	9,669 Added 18.02%	63,340 $512,000
Q1 2022 May 09, 2022	BUY	$10.12 - $28.9 $543,150 - $1.55 Million	53,671 New	53,671 $745,000
Q2 2021 Aug 13, 2021	SELL	$32.22 - $44.59 $701,654 - $971,036	-21,777 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$37.26 - $67.74 $811,411 - $1.48 Million	21,777 New	21,777 $877,000

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.